Form 10-Q Akebia Therapeutics, For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Akebia Therapeutics (AKBA) Misses Q3 EPS by 2c
November 10, 2014 7:43 AM ESTAkebia Therapeutics (NASDAQ: AKBA) reported Q3 EPS of ($0.47), $0.02 worse than the analyst estimate of ($0.45).
For earnings history and earnings-related data on Akebia Therapeutics (AKBA) click here.
... More